Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacology: impact on bladder function

K N Moore1, V A Richardson

  • 1King's College London, England.

Ostomy/Wound Management
|September 18, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary.

Gynecologic oncology·2025
Same author

Dostarlimab and niraparib in primary advanced ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Design of a randomized controlled trial to test the efficacy of interrupting sitting on type 2 diabetes risk factors in children with overweight/obesity: The sedentary behavior study 3 protocol.

Contemporary clinical trials·2025
Same author

Clinical trial screening in gynecologic oncology: Defining the need and identifying best practices.

Gynecologic oncology·2024
Same author

Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO).

Gynecologic oncology·2023
Same journal

A Descriptive, Qualitative Study to Explore the Pain Experience During Negative Pressure Wound Therapy for Postsurgical Abdominal Wounds.

Ostomy/wound management·2018
Same journal

Cultivating Incontinence-associated Dermatitis Prevention Practices in an Australian Local Health District: A Quasi-experimental Study.

Ostomy/wound management·2018
Same journal

Early and Late Closure of Loop Ileostomies: A Retrospective Comparative Outcomes Analysis.

Ostomy/wound management·2018
Same journal

A Retrospective, Descriptive Analysis of Hospital-acquired Deep Tissue Injuries.

Ostomy/wound management·2018
Same journal

Outcomes of a Quality Improvement Program to Reduce Hospital-acquired Pressure Ulcers in Pediatric Patients.

Ostomy/wound management·2018
Same journal

Effect of Music Therapy on Pain Perception, Anxiety, and Opioid Use During Dressing Change Among Patients With Burns in India: A Quasi-experimental, Cross-over Pilot Study.

Ostomy/wound management·2018
See all related articles

Many medications impact bladder function, with older adults being particularly susceptible to drug-induced urinary incontinence. This review covers pharmacologic and non-pharmacologic therapies for various incontinence types.

Area of Science:

  • Pharmacology
  • Geriatrics
  • Urology

Background:

  • Medications can improve or impair bladder function.
  • Elderly patients are vulnerable to adverse drug effects, including urinary incontinence.
  • Understanding drug-receptor interactions in the bladder is crucial.

Purpose of the Study:

  • To review pharmacologic and non-pharmacologic therapies for urinary incontinence.
  • To identify medications that impair bladder function, especially in the elderly.
  • To discuss current research in incontinence pharmacotherapy.

Main Methods:

  • Literature review of pharmacologic and non-pharmacologic treatments for urinary incontinence.
  • Identification of clinically significant medications based on efficacy, dosage, pharmacokinetics, and side effects.

Related Experiment Videos

  • Categorization of drugs contributing to impaired bladder function.

    • Main Results:

    • Detailed discussion of pharmacologic therapies for stress, urge, reflex, and overflow urinary incontinence.
    • Identification of over-the-counter, prescription, and social drugs that may cause bladder dysfunction.
    • Mention of ongoing research into novel incontinence treatments.

    Conclusions:

    • Medication management is essential for preventing and treating urinary incontinence, particularly in elderly patients.
    • Both pharmacologic and non-pharmacologic approaches are valuable in managing incontinence.
    • Awareness of drug-induced bladder dysfunction is critical for healthcare providers.